By Alastair Moore, co-founder and director of Hanway Associates.
The global image of European cannabis is changing, again.
Back in 2016, there were very few North Americans interested in what was happening this side of the Atlantic. A couple of early movers, including Tilray’s Brendan Kennedy. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
The global image of European cannabis is changing, again.
Back in 2016, there were very few North Americans interested in what was happening this side of the Atlantic. A couple of early movers, including Tilray’s Brendan Kennedy, were in London raising money and engaging policymakers. Researchers, advocacy groups, and activists made up 95% of the legal European ‘cannabis sector’.
When Germany legalised medical cannabis in 2017 something changed. European cannabis, and the commercial opportunities that would come with it, were now a very real possibility. Licences became highly sought after and executives from Canadian companies began flying in for meetings with politicians, regulators, and in some cases army colonels.